EGFR and neoplasm: Notably, ERBB family members activated downstream of signaling pathways are widespread, including the PI3K–AKT–mTOR and MAPK pathways, which not only participate in the endogenous carcinogenic pathway but also affect the tumor immune microenvironment (Yarden and Pines, 2012).